Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase

Clinical Cancer Research

Volumn 6, Issue 4, 2000, Pages 1322-1327

  Salonga, Dennis ^a   Danenberg, Kathleen D ^a   Johnson, Martin ^b   Metzger, Ralf ^a   Groshen, Susan ^a   Tsao Wei, Denice D ^a   Lenz, Heinz Josef ^a   Leichman, C Gail ^a   Leichman, Lawrence ^a   Diasio, Robert B ^b   Danenberg, Peter V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; FOLINIC ACID; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; GENE EXPRESSION REGULATION; HUMAN; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; DIHYDROURACIL DEHYDROGENASE (NADP); DRUG ADMINISTRATION SCHEDULE; ENZYMES; FLUOROURACIL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFUSIONS, INTRAVENOUS; OXIDOREDUCTASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE;

EID: 0034048729     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Moertel, C. G. Chemotherapy for colorectal cancer. N. Engl. J. Med., 330: 1136-1142, 1994.
2. Soros, G. A., Grogan, L. M., and Allegra, C. J. Preclinical and clinical aspects of biomodulation of 5-fluorouracil. Cancer Treat. Rev., 20: 11-49, 1994.
3. Leichman, C. G., Lenz, H-J., Leichman, L., Danenberg, K., Baranda, J., Groshen, S., Boswell, W., Metzger, R., Tan, M., and Danenberg, P. V. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted infusion 5-fluorouracil and weekly leucovorin. J. Clin. Oncol., 15: 3223-3229, 1997.
4. Metzger, R., Danenberg, K. D., Leichman, C. G., Salonga, D., Schwartz. E. L., Wadler, S. Lenz, H-J., Groshen, S., Leichman, L., and Danenberg, P. V. High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with non-response to 5-fluorouracil. Clin. Cancer Res., 4: 2371-2376, 1998.
5. Naguib, F. N. M., El Kouni, A. M., and Cha, S. Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res., 45: 5405-5412, 1985.
6. Lu, Z., Zhang, R., and Diasio, R. B. Purification and characterization of dihydropyrimidine dehydrogenase from human liver. J. Biol. Chem., 267: 17102-17109, 1992.
7. Johnson, M. R., Wang, K., Tillmanns, S., Albin, N., and Diasio, R. B. Structural organization of the human dihydropyrimidine dehydrogenase gene. Cancer Res., 57: 1660-1663, 1997.
8. Heggie, D., Sommadossi, J. P., Cross, D. S., Huster, W. J., and Diasio, R. B. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer Res., 47: 2203-2206, 1987.
9. Grem, J. L., Yee, L. K., Venzon, D. J., Takimoto, C. H., and Allegra, C. J. Inter-and intra-individual variation in dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells. Cancer Chemother. Pharmacol., 40: 117-125, 1997.
10. Harris, B. E., Song, R., He, Y. J., Soong, S. J., and Diasio, R. B. Relationship between dihydropyrimidine dehydrogenase activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. Cancer Res., 50: 197-201, 1990.
11. Lyss, A. P., Lilenbaum, R. C., Harris, B. E., and Diasio, R. B. Severe 5-fluorouracil toxicity in a patient with decreased dihydropyrimidine dehydrogenase activity. Cancer Investig., 11: 239-240, 1993.
12. Cao, S., Rustum, Y. M., and Spector, T. 5-Ethynyluracil modulation of the efficacy and therapeutic index in rats bearing advanced colorectal carcinoma. Cancer Res., 54: 1507-1510, 1994.
13. Etienne, M. C., Cheradame, S., Fischel, J. L., Formento, P., Dassonville, O., Renee, N., Schneider, M., Thyss, A., Demard, F, and Milano, G. Response to fluorouracil therapy in cancer patients: the role of intratumoral dihydropyrimidine dehydrogenase activity. J. Clin. Oncol., 13: 1663-1670, 1995.
14. Beck, A., Etienne, M. C., Cheradame, S., Fischel, J. L., Formento, P., Renee, N., and Milano, G. A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumor sensitivity to 5-fluorouracil. Eur. J. Cancer, 30: 1517-1522, 1994.
15. Leichman, C. G., Leichman, L., Spears, C. P., Rosen, P. J., Jeffers, S., and Groshen, S. Prolonged continuous infusion of fluorouracil with weekly bolus leucovorin: a Phase II study in patients with disseminated gastrointestinal cancers. J. Natl. Cancer Inst., 85: 41-44, 1993.
16. Green, S., and Weiss, G. R. Southwest Oncology Group standard response criteria, endpoint definitions, and toxicity criteria. Investig. New Drugs, 10: 239-253, 1992.
17. Horikoshi, T., Danenberg, K. D., Stadlbauer, T. H. W., Volkenandt, M., Shea, L. L. C., Aigner, K., Gustavsson, B., Leichman, L., Frösing, R., Ray, M., Gibson, N. W., Spears, C. P., and Danenberg, P. V. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res., 52: 108-116, 1992.
18. Lenz, H-J., Hill, C., Danenberg, K. D., Leichman, L. L., Priest, D. G., and Danenberg, P. V. Rapid quantitative PCR for determination of relative gene expressions in tissue specimens. PCR Methods Appl., 4: 305-309, 1995.
19. Johnston, P. G., Lenz, H-J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V., and Leichman, L. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res., 55: 1407-1412, 1995.
20. Kuo, D. Y-S., Mallick, S., Shen, H-J., DeVictoria, C., Jones, J., Fields, A. L., Goldberg, G. L., Runowicz, C. D., and Horwitz, S. B. Clin. Cancer Res., 2: 1981-1992, 1996.
21. 2 statistics. Biometrics, 38: 1011-1016, 1982.
22. 2 statistics for small samples. Biometrics, 38: 1017-1023, 1982.
23. Hoolander, M., and Wolfe, N. A. Statistical Methods. New York: John Wiley & Sons, 1973.
24. Graf, W., Pählman, L., Bergstrom, R., and Glimelius, B. The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer. Br. J. Cancer, 70: 559-563, 1994.
25. Saltz, L., Danenberg, K., Paty, P., Kelsen, D., Kemeny, N., Salonga, D., Park, J. M., and Danenberg, P. High thymidylate synthase activity does not preclude activity of CPT-11 in colorectal cancer (CRC). Proc. Am. Soc. Clin. Oncol., 17: 1080, 1998.